Skip to main navigation Skip to search Skip to main content

CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma

  • Koichiro Kanamori
  • , Kentaro Suina
  • , Takehito Shukuya
  • , Fumiyuki Takahashi
  • , Takuo Hayashi
  • , Kieko Hara
  • , Tsuyoshi Saito
  • , Yoichiro Mitsuishi
  • , Shoko Sonobe Shimamura
  • , Wira Winardi
  • , Ken Tajima
  • , Ryo Ko
  • , Tomoyasu Mimori
  • , Tetsuhiko Asao
  • , Masayoshi Itoh
  • , Hideya Kawaji
  • , Yoshiyuki Suehara
  • , Kazuya Takamochi
  • , Kenji Suzuki
  • , Kazuhisa Takahashi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry